Hospitals are using dramatic TV spots to attract lucrative patients into their hospitals as health care costs and industry competition escalate.
The rules, said to be proposed to reduce “burdensome” regulations, would no longer penalize hospitals if too many of their patients die following transplants.
New drugs that promise a cure for the 3.5 million Americans with chronic hepatitis also are benefiting another category of patients: those awaiting life-saving organ transplants.
“It’s all about the money,” says one surgeon of the battle over which hospitals can perform transcatheter aortic valve replacement, also known as TAVR.
The centers started as low-cost alternatives for minor surgeries. They now outnumber hospitals, and regulators OK’d ever-widening array of outpatient procedures
It is intuitive to think that when something is broken in the knee, fixing it with surgery is necessary. Research shows this is not necessarily so.